See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2020_Celldex_Therapeutics_Inc.pdf
Logs
info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 17,264,000 |
1 | LiabilitiesCurrent | 11,643,000 |
2 | remainder_Liabilities | 0 |
3 | AssetsCurrent | 66,698,000 |
4 | AssetsNoncurrent | 3,514,000 |
5 | PropertyPlantAndEquipmentNet | 4,031,000 |
6 | Goodwill | 48,690,000 |
7 | remainder_Assets | 0 |
8 | GeneralAndAdministrativeExpense | 15,426,000 |
9 | ResearchAndDevelopmentExpense | 42,672,000 |
10 | remainder_Expenses | 506,000 |
11 | remainder_Revenues | 7,726,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 36,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 28,907,000 |
1 | Assets | 122,933,000 |
2 | Expenses | 58,604,000 |
3 | Revenues | 7,726,000 |
4 | StockholdersEquity | 94,026,000 |
5 | NetIncome | -50,878,000 |
6 | ComprehensiveNetIncome | -50,860,000 |
7 | BaseVar | 109,103,000 |
8 | EconomicCapitalRatio | 0.383 |